TORONTO, - Auto Control Medical, a privately owned Toronto-based company that distributes self-monitoring medical devices, is launching EZSCAN in Canada. EZSCAN is a device designed to identify those at risk of developing Type 2 diabetes. This non-invasive testing is painless and takes less than three minutes for the results. "It was developed to identify prediabetes," said Robert Burgy, President of Auto Control Medical, "if you know you are at risk, then you can do something to try and prevent it from progressing to Type 2 diabetes."